Page 26 - Sun Pharma

Top 10 biz headlines: Carnage on D-Street, Sun Pharma mulls share buyback

From RBI offering $2-bn swaps to Tata Sons buying group firms' shares, here are the top 10 business headlines for the day

Share buyback plan fails to lift Sun Pharma; stock hits over 7-year low

The drugmaker announced that its board will meet on Tuesday, March 17, 2020 to consider the buyback of company's shares

Sun Pharma board to consider buyback of shares next week

Analyst say more promoters likely to seek ways to cushion share price

Sun Pharma stock sheds 15% on price fixing concerns, slow portfolio ramp-up

The near-term worry for the company is the ongoing investigation by the US Department of Justice related to price fixing and cartelisation by generic companies

Pharma stocks gain for second straight day; Sun Pharma surges 12% in 2 days

According to CARE Ratings, pharma exports from India are estimated to rise by about 11 to 12 per cent on a year on year.

Sebi probe finds violation of listing and disclosure norms by Sun Pharma

Allegations of fund diversion not confirmed

Today's picks: From Sun Pharma to BPCL, hot stocks to watch on Thursday

For Sun Pharma, keep a stop at 407 and go short

Weekly stock picks by Religare Broking: Buy Balkrishna Industries, HUL

Balkrishna Industries is currently hovering in a range while holding strong above the support zone of 20 EMA on the daily charts

Sun Pharma's Q3 profit before tax declines 22% to Rs 1,351.3 crore

The company's India sales posted 13% growth

Sun Pharma net profit declines 27% to Rs 914 cr in December quarter

The company had posted a net profit of Rs 1,241.85 crore for the corresponding period of the previous fiscal

Market Ahead, February 6: All you need to know before the Opening Bell

A total of 135 companies are scheduled to announce their December quarter earnings today including Eicher Motors, Hero MotoCorp, Sun Pharma, and RITES

Market Ahead, February 3: Top factors that could guide markets this week

On the corporate earnings front, Bharti Airtel, Lupin, Sun Pharma, and Mahindra & Mahindra are among the major companies scheduled to declare their October-December results this week

Nifty outlook and top trading ideas by CapitalVia Global Research

Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

Pharma shares in focus; Dr Reddy's, Divi's, Granules hit 52-week highs

Lupin, Sun Pharmaceutical, Cadila Healthcare, Aarti Drugs and Aurobindo Pharma were up in the range of 2 per cent to 3 per cent.

Dilip Shanghvi staring at huge loss as Suzlon Energy heads to bankruptcy

Dilip Shanghvi, the Sun Pharma promoter has 23% in renewable power firm that has failed to get debt recast plan

Nifty view & top trading ideas by CapitalVia: Buy Pidilite Ind, Sun Pharma

Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

FDA observation, forensic audit by Sebi may keep Sun Pharma under pressure

Halol plant observations add to worries on the extent of upsides from specialty drugs

Sun Pharma declines nearly 3% as Halol facility gets 8 US FDA observations

The company said it was preparing the response to the observations, which will be submitted to the US FDA within 15 business days

Sun Pharma gets partial relief from US court in litigation on generic drugs

Shares of the company on Monday ended 2.18 per cent lower at Rs 440 apiece on the BSE

Specialty drugs, domestic growth prospects positives for Sun Pharma stock

While pricing pressure in the US generics is also stabilising, the specialty products that Sun Pharma has been investing in are seen as a growth driver of its US business